{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T22:16:28Z","timestamp":1770329788369,"version":"3.49.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T00:00:00Z","timestamp":1696982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T00:00:00Z","timestamp":1696982400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Parasit."],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1007\/s11686-023-00719-5","type":"journal-article","created":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T20:13:41Z","timestamp":1697055221000},"page":"807-819","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Parasitic Protozoans: Exploring the Potential of N,N\u2019-Bis[2-(5-bromo-7-azabenzimidazol-1-yl)-2-oxoethyl]ethylene-1,3-Diamine and Its Cyclohexyl-1,2-diamine Analogue as TryR and Pf-DHODH Inhibitors"],"prefix":"10.1007","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1480-0570","authenticated-orcid":false,"given":"Kola A.","family":"Oluwafemi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oluwatoba E.","family":"Oyeneyin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Damilare D.","family":"Babatunde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric B.","family":"Agbaffa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane A.","family":"Aigbogun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oluwakayode O.","family":"Odeja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abiodun V.","family":"Emmanuel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,10,11]]},"reference":[{"issue":"8","key":"719_CR1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0009668","volume":"15","author":"S Sutrave","year":"2021","unstructured":"Sutrave S, Richter MH (2021) The Truman Show for protozoan parasites: A review of in vitro cultivation platforms. PLoS Negl Trop Dis 15(8):e0009668. https:\/\/doi.org\/10.1371\/journal.pntd.0009668","journal-title":"PLoS Negl Trop Dis"},{"key":"719_CR2","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s13104-020-04977-8","volume":"13","author":"M Fofana","year":"2020","unstructured":"Fofana M, Mitri C, Diallo D, Rotureau B, Diagne CT, Gaye A, Ba Y, Diame C, Diallo M, Dia I (2020) Possible influence of Plasmodium\/Trypanosoma co-infections on the vectorial capacity of Anopheles mosquitoes. BMC Res Notes 13:127. https:\/\/doi.org\/10.1186\/s13104-020-04977-8","journal-title":"BMC Res Notes"},{"key":"719_CR3","doi-asserted-by":"publisher","first-page":"20212155","DOI":"10.1098\/rspb.2021.2155","volume":"289","author":"F Venter","year":"2022","unstructured":"Venter F, Matthews KR, Silvester E (2022) Parasite co-infection: an ecological, molecular and experimental perspective. Proc R Soc B 289:20212155. https:\/\/doi.org\/10.1098\/rspb.2021.2155","journal-title":"Proc R Soc B"},{"key":"719_CR4","doi-asserted-by":"publisher","first-page":"23777","DOI":"10.1038\/s41598-021-03295-8","volume":"11","author":"KU Kotepui","year":"2021","unstructured":"Kotepui KU, Masangkay FR, De Jesus MG, Kotepui M (2021) Prevalence and outcomes of malaria as co-infection among patients with human African trypanosomiasis: a systematic review and meta-analysis. Sci Rep 11:23777. https:\/\/doi.org\/10.1038\/s41598-021-03295-8","journal-title":"Sci Rep"},{"issue":"1","key":"719_CR5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1756-3305-1-3","volume":"1","author":"D Steverding","year":"2008","unstructured":"Steverding D (2008) The history of African trypanosomiasis. Parasit Vectors 1(1):3. https:\/\/doi.org\/10.1186\/1756-3305-1-3","journal-title":"Parasit Vectors"},{"key":"719_CR6","doi-asserted-by":"publisher","DOI":"10.1017\/S1462399409001252","volume":"11","author":"SR Wilkinson","year":"2009","unstructured":"Wilkinson SR, Kelly JM (2009) Trypanocidal drugs: mechanisms, resistance and new targets. Expert Rev Mol Med 11:e31. https:\/\/doi.org\/10.1017\/S1462399409001252","journal-title":"Expert Rev Mol Med"},{"issue":"3","key":"719_CR7","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/s0001-706x(02)00188-2","volume":"84","author":"I Boibessot","year":"2002","unstructured":"Boibessot I, Turner CM, Watson DG, Goldie E, Connel G, McIntosh A, Grant MH, Skellern GG (2002) Acta Trop 84(3):219\u2013228. https:\/\/doi.org\/10.1016\/s0001-706x(02)00188-2","journal-title":"Acta Trop"},{"key":"719_CR8","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1128\/AAC.37.5.1163","volume":"37","author":"SK Ndoutamia","year":"1993","unstructured":"Ndoutamia SK, Moloo NB, Murphy AS (1993) Derivation and characterization of a quinapyramine-resistant clone of Trypanosoma congolense. Antimicrob Agents Chemother 37:1163\u20131166. https:\/\/doi.org\/10.1128\/AAC.37.5.1163","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"719_CR9","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s11250-013-0498-9","volume":"46","author":"M Ranjithkumar","year":"2014","unstructured":"Ranjithkumar M, Saravanan BC, Yadav SC, Kumar R, Singh R, Dey S (2014) Neurological trypanosomiasis in quinapyramine sulfate-treated horses\u2014a breach of the blood-brain barrier? Trop Anim Health Prod 46(2):371\u2013377. https:\/\/doi.org\/10.1007\/s11250-013-0498-9","journal-title":"Trop Anim Health Prod"},{"key":"719_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.ppat.1001204","volume":"6","author":"IM Vincent","year":"2010","unstructured":"Vincent IM, Creek D, David G, Watson DG, Kamleh MA, Debra J, Woods D, Wong PE, Burchmore RJS, Michael P, Barrett MP (2010) A molecular mechanism for eflornithine resistance in African trypanosomes. PLoS Pathog 6:1\u20139. https:\/\/doi.org\/10.1371\/journal.ppat.1001204","journal-title":"PLoS Pathog"},{"key":"719_CR11","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.pt.2003.09.002","volume":"19","author":"AH Fairlamb","year":"2003","unstructured":"Fairlamb AH (2003) Chemotherapy of human African trypanosomiasis: current and future prospects. Trends Parasitol 19:488\u2013494. https:\/\/doi.org\/10.1016\/j.pt.2003.09.002","journal-title":"Trends Parasitol"},{"key":"719_CR12","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1051\/parasite\/2013038","volume":"20","author":"M Dethoua","year":"2013","unstructured":"Dethoua M, Nzoumbou-Boko R, Truc P, Daulou\u00e8de S, Courtois P, Bucheton B, Cuny G, Semballa S, Vincendeau P (2013) Evaluation of trypanocidal drugs used for human African trypanosomosis against Trypanosoma lewisi. Parasite 20:39. https:\/\/doi.org\/10.1051\/parasite\/2013038","journal-title":"Parasite"},{"key":"719_CR13","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s12936-019-2724-z","volume":"18","author":"EG Tse","year":"2009","unstructured":"Tse EG, Korsik M, Todd MH (2009) The past, present and future of anti-malarial medicines. Malar J 18:93. https:\/\/doi.org\/10.1186\/s12936-019-2724-z","journal-title":"Malar J"},{"issue":"12","key":"719_CR14","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1002\/cmdc.200900262","volume":"4","author":"D Spinks","year":"2009","unstructured":"Spinks D, Shanks EJ, Cleghorn LAT, McElroy S, Jones D, James D, Fairlamb AH, Frearson JA, Wyatt PG, Gilbert IH (2009) Investigation of trypanothione reductase as a drug target in Trypanosoma brucei. ChemMedChem 4(12):2060\u20132069. https:\/\/doi.org\/10.1002\/cmdc.200900262","journal-title":"ChemMedChem"},{"issue":"3","key":"719_CR15","doi-asserted-by":"publisher","first-page":"226","DOI":"10.2174\/187152610791163336","volume":"10","author":"MA Phillips","year":"2010","unstructured":"Phillips MA, Rathod PK (2010) Plasmodium dihydroorotate dehydrogenase: a promising target for novel anti-malarial chemotherapy. Infect Disord Drug Targets 10(3):226\u2013239. https:\/\/doi.org\/10.2174\/187152610791163336","journal-title":"Infect Disord Drug Targets"},{"issue":"8","key":"719_CR16","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1002\/cmdc.201402032","volume":"9","author":"E Persch","year":"2014","unstructured":"Persch E, Bryson S, Todoroff NK, Eberle C, Pai EF, Krauth-Siegel RL, Diederich F (2014) Binding to large enzyme pockets: small-molecule inhibitors of trypanothione reductase. ChemMedChem 9(8):1880\u20131891. https:\/\/doi.org\/10.1002\/cmdc.201402032","journal-title":"ChemMedChem"},{"issue":"5","key":"719_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0008339","volume":"14","author":"L Turcano","year":"2020","unstructured":"Turcano L, Battista T, De Haro ET, Missineo A, Alli C, Paonessa G, Colotti G, Harper S, Fiorillo A, Ilari A, Bresciani A (2020) Spiro-containing derivatives show antiparasitic activity against\u00a0Trypanosoma brucei\u00a0through inhibition of the trypanothione reductase enzyme. PLoS Negl Trop Dis 14(5):e0008339. https:\/\/doi.org\/10.1371\/journal.pntd.0008339","journal-title":"PLoS Negl Trop Dis"},{"key":"719_CR18","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1021\/jm960814j","volume":"41","author":"C Chan","year":"1998","unstructured":"Chan C, Yin H, Garforth J, McKie JH, Jaouhari R, Speers P, Douglas KT, Rock PJ, Yardley V, Croft SL, Fairlamb AH (1998) Phenothiazine inhibitors of trypanothione reductase as potential antitrypanosomal and antileishmanial drugs. J Med Chem 41:148\u2013156. https:\/\/doi.org\/10.1021\/jm960814j","journal-title":"J Med Chem"},{"issue":"6","key":"719_CR19","doi-asserted-by":"publisher","first-page":"784","DOI":"10.3109\/14756366.2011.604319","volume":"27","author":"MH Duyzend","year":"2012","unstructured":"Duyzend MH, Clark CT, Simmons SL, Johnson WB, Larson AM, Leconte AM, Wills AW, Ginder-Vogel M, Wilhelm AK, Czechowicz JA, Alberg DG (2012) Synthesis and evaluation of substrate analogue inhibitors of trypanothione reductase. J Enzyme Inhib Med Chem 27(6):784\u2013794. https:\/\/doi.org\/10.3109\/14756366.2011.604319","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"8","key":"719_CR20","doi-asserted-by":"publisher","first-page":"9227","DOI":"10.1021\/acsomega.8b01573","volume":"3","author":"S Kokkonda","year":"2018","unstructured":"Kokkonda S, El Mazouni F, White KL, White J, Shackleford DM, Lafuente-Monasterio MJ, Rowland P, Manjalanagara K, Joseph JT, Garcia-P\u00e9rez A, Fernandez J, Gamo FJ, Waterson D, Burrows JN, Palmer MJ, Charman SA, Rathod PK, Phillips MA (2018) Isoxazolopyrimidine-Based Inhibitors of Plasmodium falciparum Dihydroorotate Dehydrogenase with Antimalarial Activity. ACS Omega 3(8):9227\u20139240. https:\/\/doi.org\/10.1021\/acsomega.8b01573","journal-title":"ACS Omega"},{"key":"719_CR21","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.ejmech.2018.11.044","volume":"163","author":"AC Pippione","year":"2019","unstructured":"Pippione AC, Sainas S, Goyal P, Fritzson I, Cassiano GC, Giraudo A, Giorgis M, Tavella TA, Bagnati R, Rolando B, Caing-Carlsson R, Costa FTM, Andrade CH, Al-Karadaghi S, Boschi D, Friemann R, Lolli ML (2019) Hydroxyazole scaffold-based Plasmodium falciparum dihydroorotate dehydrogenase inhibitors: Synthesis, biological evaluation and X-ray structural studies. Eur J Med Chem 163:266\u2013280. https:\/\/doi.org\/10.1016\/j.ejmech.2018.11.044","journal-title":"Eur J Med Chem"},{"key":"719_CR22","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1080\/1062936X.2016.1189959","volume":"27","author":"VK Vyas","year":"2016","unstructured":"Vyas VK, Qureshi G, Ghate M, Patel H, Dalai S (2016) Identification of novel PfDHODH inhibitors as antimalarial agents via pharmacophore-based virtual screening followed by molecular docking and in vivo antimalarial activitySAR QSAR. Environ Res 27:427\u2013440. https:\/\/doi.org\/10.1080\/1062936X.2016.1189959","journal-title":"Environ Res"},{"issue":"1","key":"719_CR23","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.bmcl.2005.09.045","volume":"16","author":"T Heikkil\u00e4","year":"2006","unstructured":"Heikkil\u00e4 T, Thirumalairajan S, Davies M, Parsons MR, McConkey AG, Fishwick CW, Johnson AP (2006) The first de novo designed inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase. Bioorg Med Chem Lett 16(1):88\u201392. https:\/\/doi.org\/10.1016\/j.bmcl.2005.09.045","journal-title":"Bioorg Med Chem Lett"},{"issue":"1","key":"719_CR24","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/s0969-2126(00)00077-0","volume":"8","author":"S Liu","year":"2000","unstructured":"Liu S, Neidhardt EA, Grossman TH, Ocain T, Clardy J (2000) Structures of human dihydroorotate dehydrogenase in complex with antiproliferative agents. Structure 8(1):25\u201333. https:\/\/doi.org\/10.1016\/s0969-2126(00)00077-0","journal-title":"Structure"},{"issue":"43","key":"719_CR25","doi-asserted-by":"publisher","first-page":"33054","DOI":"10.1074\/jbc.M110.162081","volume":"285","author":"ML Booker","year":"2010","unstructured":"Booker ML, Bastos CM, Kramer ML, Barker RH Jr, Skerlj R, Sidhu AB, Deng X, Celatka C, Cortese JF, Guerrero Bravo JE, Crespo Llado KN, Serrano AE, Angulo-Barturen I, Jim\u00e9nez-D\u00edaz MB, Viera S, Garuti H, Wittlin S, Papastogiannidis P, Lin JW, Janse CJ, Khan SM, Duraisingh M, Coleman B, Goldsmith EJ, Phillips MA, Munoz B, Wirth DF, Klinger JD, Wiegand R, Sybertz E (2010) Novel inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase with anti-malarial activity in the mouse model. J Biol Chem 285(43):33054\u201333064. https:\/\/doi.org\/10.1074\/jbc.M110.162081","journal-title":"J Biol Chem"},{"issue":"1","key":"719_CR26","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1021\/jm060873p","volume":"50","author":"RA Stavenger","year":"2007","unstructured":"Stavenger RA, Cui H, Dowdell SE, Franz RG, Gaitanopoulos DE, Goodman KB, Hilfiker MA, Ivy RL, Leber JD, Marino JP Jr, Oh HJ, Viet AQ, Xu W, Ye G, Zhang D, Zhao Y, Jolivette LJ, Head MS, Semus SF, Elkins PA, Kirkpatrick RB, Dul E, Khandekar SS, Yi T, Jung DK, Wright LL, Smith GK, Behm DJ, Doe CP, Bentley R, Chen ZX, Hu E, Lee D (2007) Discovery of aminofurazan-azabenzimidazoles as inhibitors of rho-kinase with high kinase selectivity and antihypertensive activity. J Med Chem 50(1):2\u20135. https:\/\/doi.org\/10.1021\/jm060873p","journal-title":"J Med Chem"},{"issue":"5","key":"719_CR27","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1016\/j.bmcl.2012.01.018","volume":"22","author":"T Wang","year":"2012","unstructured":"Wang T, Block MA, Cowen S, Davies AM, Devereaux E, Gingipalli L, Johannes J, Larsen NA, Su Q, Tucker JA, Whitston D, Wu J, Zhang HJ, Zinda M, Chuaqui C (2012) Discovery of azabenzimidazole derivatives as potent, selective inhibitors of TBK1\/IKK\u03b5 kinases. Bioorg Med Chem Lett 22(5):2063\u20132069. https:\/\/doi.org\/10.1016\/j.bmcl.2012.01.018","journal-title":"Bioorg Med Chem Lett"},{"issue":"10","key":"719_CR28","doi-asserted-by":"publisher","first-page":"6032","DOI":"10.1128\/AAC.02959-14","volume":"58","author":"KH Ansell","year":"2014","unstructured":"Ansell KH, Jones HM, Whalley D, Hearn A, Taylor DL, Patin EC, Chapman TM, Osborne SA, Wallace C, Birchall K, Large J, Bouloc N, Smiljanic-Hurley E, Clough B, Moon RW, Green JL, Holder AA (2014) Biochemical and antiparasitic properties of inhibitors of the Plasmodium falciparum calcium-dependent protein kinase PfCDPK1. Antimicrob Agents Chemother 58(10):6032\u20136043. https:\/\/doi.org\/10.1128\/AAC.02959-14","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"719_CR29","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1021\/ml500353p","volume":"6","author":"PA Barsanti","year":"2014","unstructured":"Barsanti PA, Aversa RJ, Jin X, Pan Y, Lu Y, Elling R, Jain R, Knapp M, Lan J, Lin X, Rudewicz P, Sim J, Taricani L, Thomas G, Xiao L, Yue Q (2014) Structure-based drug design of novel potent and selective tetrahydropyrazolo[1,5-a]pyrazines as ATR inhibitors. ACS Med Chem Lett 6(1):37\u201341. https:\/\/doi.org\/10.1021\/ml500353p","journal-title":"ACS Med Chem Lett"},{"key":"719_CR30","unstructured":"Oluwafemi KA (2020) Synthesis, characterization and bioactivity of N,N\u2019-Bis[2-(5-bromo7-azabenzimidazol-1-yl)-2-oxoethyl]ethylene-1,3-diamine and the\u2013cyclohexyl-1,2diamine Analogue. J Chem Soc Nigeria 45:253\u2013258. https:\/\/journals.chemsociety.org.ng\/index.php\/jcsn\/article\/view\/445\/506. Accessed 2 Mar 2022"},{"key":"719_CR31","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.pt.2012.12.005","volume":"29","author":"N Baker","year":"2013","unstructured":"Baker N, de Koning HP, M\u00e4ser HP, Horn D (2013) Drug resistance in African trypanosomiasis: the melarsoprol and pentamidine story. Trends parasitol 29:110\u2013118. https:\/\/doi.org\/10.1016\/j.pt.2012.12.005","journal-title":"Trends parasitol"},{"issue":"1\u20132","key":"719_CR32","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.drup.2007.02.004","volume":"10","author":"V Delespaux","year":"2007","unstructured":"Delespaux V, de Koning HP (2007) Drugs and drug resistance in African trypanosomiasis. Drug Resist Updat 10(1\u20132):30\u201350. https:\/\/doi.org\/10.1016\/j.drup.2007.02.004","journal-title":"Drug Resist Updat"},{"key":"719_CR33","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/nrmicro.2017.161","volume":"16","author":"K Haldar","year":"2018","unstructured":"Haldar K, Bhattacharjee S, Safeukui I (2018) Drug resistance in Plasmodium. Nat Rev Microbiol 16:156\u2013170. https:\/\/doi.org\/10.1038\/nrmicro.2017.161","journal-title":"Nat Rev Microbiol"},{"key":"719_CR34","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1172\/JCI21682","volume":"113","author":"NJ White","year":"2004","unstructured":"White NJ (2004) Antimalarial drug resistance. J Clin Invest 113:1084\u20131092. https:\/\/doi.org\/10.1172\/JCI21682","journal-title":"J Clin Invest"},{"key":"719_CR35","unstructured":"Oyeneyin OE, Abayomi TG, Ipinloju N, Agbaffa EB, Akerele DD, Arobadade OA (2021) Investigation of amino chalcone derivatives as anti-proliferative agents against MCF-7 breast cancer cell lines-DFT, molecular docking and pharmacokinetics studies. Adv J Chem A 4(4):288\u2013299. http:\/\/www.ajchem-a.com\/article_133740.html"},{"issue":"7","key":"719_CR36","doi-asserted-by":"publisher","first-page":"5648","DOI":"10.1063\/1.464913","volume":"98","author":"AD Becke","year":"1993","unstructured":"Becke AD (1993) Density-functional thermochemistry. III. The role of exact exchange. J Chem Phys 98(7):5648\u20135652. https:\/\/doi.org\/10.1063\/1.464913","journal-title":"J Chem Phys"},{"issue":"11","key":"719_CR37","doi-asserted-by":"publisher","first-page":"3099","DOI":"10.1021\/ci300367a","volume":"52","author":"F Cheng","year":"2012","unstructured":"Cheng F, Li W, Zhou Y, Shen J, Wu Z, Liu G, Lee PW, Tang Y (2012) admetSAR: a comprehensive source and free tool for assessment of chemical ADMET properties. J Chem Inf Model 52(11):3099\u20133105. https:\/\/doi.org\/10.1021\/ci300367a","journal-title":"J Chem Inf Model"},{"key":"719_CR38","unstructured":"http:\/\/www.rcsb.org\/pdb\/home\/home.do. Accessed 12 Apr 2022"},{"key":"719_CR39","unstructured":"Schr\u00f6dinger Release 2021\u20133: LigPrep, Schr\u00f6dinger, LLC, New York, NY, 2021, (n.d.). https:\/\/www.schrodinger.com\/products\/ligprep. Accessed 16 Mar 2022"},{"key":"719_CR40","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","volume":"27","author":"GM Sastry","year":"2013","unstructured":"Sastry GM, Adzhigirey M, Day T, Annabhimoju R, Sherman W (2013) Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments. J Comput Aided Mol Des 27:221\u2013234. https:\/\/doi.org\/10.1007\/s10822-013-9644-8","journal-title":"J Comput Aided Mol Des"},{"key":"719_CR41","unstructured":"GROMACS (2022) Welcome to the GROMACS documentation!\u2014GROMACS 2021.5 documentation, (2022). https:\/\/manual.gromacs.org\/2021-current\/index.html. Accessed 25 Apr 2022"},{"key":"719_CR42","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1002\/jcc.23354","volume":"34","author":"J Huang","year":"2013","unstructured":"Huang J, MacKerell Jr ADJ (2013) CHARMM36 all-atom additive protein force field: validation based on comparison to NMR data. J Comput Chem 34:2135\u20132145. https:\/\/doi.org\/10.1002\/jcc.23354","journal-title":"J Comput Chem"},{"key":"719_CR43","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1021\/acs.jctc.5b00935","volume":"12","author":"J Lee","year":"2016","unstructured":"Lee J, Cheng X, Swails JM, Yeom MS, Eastman PK, Lemkul JA, Wei S, Buckner J, Jeong JC, Qi Y, Jo S, Pande VS, Case DA, Brooks CL, MacKerell AD, Klauda JB, Im W (2016) CHARMM-GUI input generator for NAMD, GROMACS, AMBER, OpenMM, and CHARMM\/OpenMM simulations using the CHARMM36 additive force field. J Chem Theory Comput 12:405\u2013413. https:\/\/doi.org\/10.1021\/acs.jctc.5b00935","journal-title":"J Chem Theory Comput"},{"key":"719_CR44","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1002\/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H","volume":"18","author":"B Hess","year":"1997","unstructured":"Hess B, Bekker H, Berendsen HJC, Fraaije JGEM (1997) LINCS: a linear constraint solver for molecular simulations. J Comput Chem 18:1463\u20131472. https:\/\/doi.org\/10.1002\/(SICI)1096-987X(199709)18:12%3c1463::AID-JCC4%3e3.0.CO;2-H","journal-title":"J Comput Chem"},{"key":"719_CR45","doi-asserted-by":"publisher","first-page":"3684","DOI":"10.1063\/1.448118","volume":"81","author":"HJC Berendsen","year":"1998","unstructured":"Berendsen HJC, Postma JPM, Van Gunsteren WF, Dinola A, Haak JR (1998) Molecular dynamics with coupling to an external bath. J Chem Phys 81:3684. https:\/\/doi.org\/10.1063\/1.448118","journal-title":"J Chem Phys"},{"key":"719_CR46","doi-asserted-by":"publisher","first-page":"7182","DOI":"10.1063\/1.328693","volume":"52","author":"M Parrinello","year":"1981","unstructured":"Parrinello M, Rahman A (1981) Polymorphic transitions in single crystals: a new molecular dynamics method. J Appl Phys 52:7182\u20137190. https:\/\/doi.org\/10.1063\/1.328693","journal-title":"J Appl Phys"},{"key":"719_CR47","doi-asserted-by":"publisher","first-page":"277","DOI":"10.24820\/ark.5550190.p011.499","volume":"viii","author":"KA Oluwafemi","year":"2021","unstructured":"Oluwafemi KA, Phunguphungua S, Gqunua S, Isaacs M, Hoppe HC, Klein R, Kaye PT (2021) Synthesis and trypanocidal activity of substituted 2,4-diarylquinoline derivatives. ARKIVOC viii:277\u2013285. https:\/\/doi.org\/10.24820\/ark.5550190.p011.499","journal-title":"ARKIVOC"},{"issue":"13","key":"719_CR48","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1002\/cmdc.201800235","volume":"13","author":"MJ Lunga","year":"2018","unstructured":"Lunga MJ, Chisango RL, Weyers C, Isaacs M, Taylor D, Edkins AL, Khanye SD, Hoppe HC, Veale CGL (2018) Expanding the SAR of nontoxic antiplasmodial indolyl-3-ethanone ethers and thioethers. ChemMedChem 13(13):1353\u20131362. https:\/\/doi.org\/10.1002\/cmdc.201800235","journal-title":"ChemMedChem"},{"issue":"12","key":"719_CR49","doi-asserted-by":"publisher","first-page":"20180101","DOI":"10.1515\/psr-2018-0101","volume":"4","author":"M Athar","year":"2019","unstructured":"Athar M, Sona A, Bekono B, Ntie-Kang F (2019) Fundamental physical and chemical concepts behind \u201cdrug-likeness\u201d and \u201cnatural product-likeness.\u201d Phys Sci Rev 4(12):20180101. https:\/\/doi.org\/10.1515\/psr-2018-0101","journal-title":"Phys Sci Rev"},{"issue":"1","key":"719_CR50","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s11030-020-10062-w","volume":"25","author":"H Tandon","year":"2021","unstructured":"Tandon H, Ranjan P, Chakraborty T, Suhag V (2021) Polarizability: a promising descriptor to study chemical-biological interactions. Mol Divers 25(1):249\u2013262. https:\/\/doi.org\/10.1007\/s11030-020-10062-w","journal-title":"Mol Divers"},{"issue":"1","key":"719_CR51","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1021\/ci020378b","volume":"43","author":"C Hansch","year":"2003","unstructured":"Hansch C, Steinmetz WE, Leo AJ, Mekapati SB, Kurup A, Hoekman D (2003) On the role of polarizability in chemical-biological interactions. J Chem Inf Comput Sci 43(1):120\u2013125. https:\/\/doi.org\/10.1021\/ci020378b","journal-title":"J Chem Inf Comput Sci"},{"issue":"11","key":"719_CR52","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1002\/open.202100178","volume":"10","author":"N Flores-Holgu\u00edn","year":"2021","unstructured":"Flores-Holgu\u00edn N, Frau J, Glossman-Mitnik D (2021) Computational pharmacokinetics report, ADMET study and conceptual DFT-based estimation of the chemical reactivity properties of marine cyclopeptides. ChemistryOpen 10(11):1142\u20131149. https:\/\/doi.org\/10.1002\/open.202100178","journal-title":"ChemistryOpen"},{"issue":"1","key":"719_CR53","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1039\/c8md00472b","volume":"10","author":"L Guan","year":"2018","unstructured":"Guan L, Yang H, Cai Y, Sun L, Di P, Li W, Liu G, Tang Y (2018) ADMET-score\u2014a comprehensive scoring function for evaluation of chemical drug-likeness. MedChemComm 10(1):148\u2013157. https:\/\/doi.org\/10.1039\/c8md00472b","journal-title":"MedChemComm"},{"issue":"Suppl 1","key":"719_CR54","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1186\/1471-2377-9-S1-S1","volume":"9 Suppl 1","author":"K Tsaioun","year":"2009","unstructured":"Tsaioun K, Bottlaender M, Mabondzo A, Alzheimer\u2019s Drug Discovery Foundation (2009) ADDME\u2014Avoiding Drug Development Mistakes Early: central nervous system drug discovery perspective. BMC Neurol 9 Suppl 1(Suppl 1):S1. https:\/\/doi.org\/10.1186\/1471-2377-9-S1-S1","journal-title":"BMC Neurol"},{"key":"719_CR55","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.compbiolchem.2016.08.007","volume":"64","author":"Y Ding","year":"2016","unstructured":"Ding Y, Fang Y, Moreno J, Ramanujam J, Jarrell M, Brylinski M (2016) Assessing the similarity of ligand binding conformations with the Contact Mode Score. Comput Biol Chem 64:403\u2013413. https:\/\/doi.org\/10.1016\/j.compbiolchem.2016.08.007","journal-title":"Comput Biol Chem"},{"key":"719_CR56","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1002\/cmdc.201402032","volume":"9","author":"E Persch","year":"2014","unstructured":"Persch E, Bryson S, Todoroff NK, Eberle C, Thelemann J, Dirdjaja N, Kaiser M, Weber M, Derbani H, Brun R, Schneider G, Pai EF, Krauth-Siegel RL, Diederich F (2014) Binding to large enzyme pockets: small-molecule inhibitors of trypanothione reductase. ChemMedChem 9:1880\u20131891. https:\/\/doi.org\/10.1002\/cmdc.201402032","journal-title":"ChemMedChem"},{"issue":"1","key":"719_CR57","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1002\/PROT.20851","volume":"63","author":"OV Galzitskaya","year":"2006","unstructured":"Galzitskaya OV, Garbuzynskiy SO (2006) Entropy capacity determines protein folding. Proteins 63(1):144\u2013154. https:\/\/doi.org\/10.1002\/PROT.20851","journal-title":"Proteins"},{"key":"719_CR58","doi-asserted-by":"publisher","first-page":"14202","DOI":"10.1039\/c4ra16617e","volume":"5","author":"T Sindhu","year":"2015","unstructured":"Sindhu T, Srinivasan P (2015) Exploring the binding properties of agonists interacting with glucocorticoid receptor: an in silico approach. RSC Adv 5:14202\u201314213. https:\/\/doi.org\/10.1039\/c4ra16617e","journal-title":"RSC Adv"}],"container-title":["Acta Parasitologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11686-023-00719-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11686-023-00719-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11686-023-00719-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T21:42:47Z","timestamp":1700689367000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11686-023-00719-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,11]]},"references-count":58,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["719"],"URL":"https:\/\/doi.org\/10.1007\/s11686-023-00719-5","relation":{},"ISSN":["1230-2821","1896-1851"],"issn-type":[{"value":"1230-2821","type":"print"},{"value":"1896-1851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,11]]},"assertion":[{"value":"17 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"Not\u00a0applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}